The frequency of biallelic loss of TP53 in MM increases with disease progression, being rare in smoldering myeloma (1.2%) and increasing through relapse (20%), indicating that it is a key mechanism in the pathogenesis of the disease [10, 11]. Here, TP53 is linked to plasma cell myeloma.